Coeptis Therapeutics Holdings Expands Board of Directors with New Appointments

November 2, 2022

Biotechnology

Intensity Therapeutics Recognized with GHP Magazine’s 2026 Healthcare & Pharmaceutical Award

May 14, 2026
INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer’s Disease

May 14, 2026
XORTX Announces US$5 Million Public Offering

May 14, 2026
Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab

May 14, 2026